123 related articles for article (PubMed ID: 38544296)
1. Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition.
Gong C; Feng Y; Zhu J; Liu G; Tang Y; Li W
J Appl Toxicol; 2024 Mar; ():. PubMed ID: 38544296
[TBL] [Abstract][Full Text] [Related]
2. Development of In Silico Models for Predicting Potential Time-Dependent Inhibitors of Cytochrome P450 3A4.
Xu M; Lu Z; Wu Z; Gui M; Liu G; Tang Y; Li W
Mol Pharm; 2023 Jan; 20(1):194-205. PubMed ID: 36458739
[TBL] [Abstract][Full Text] [Related]
3. Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties.
Zahid H; Tayara H; Chong KT
Arch Toxicol; 2024 Apr; ():. PubMed ID: 38619593
[TBL] [Abstract][Full Text] [Related]
4. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes.
Plonka W; Stork C; Šícho M; Kirchmair J
Bioorg Med Chem; 2021 Sep; 46():116388. PubMed ID: 34488021
[TBL] [Abstract][Full Text] [Related]
5. Large-scale evaluation of cytochrome P450 2C9 mediated drug interaction potential with machine learning-based consensus modeling.
Rácz A; Keserű GM
J Comput Aided Mol Des; 2020 Aug; 34(8):831-839. PubMed ID: 32221780
[TBL] [Abstract][Full Text] [Related]
6. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
[TBL] [Abstract][Full Text] [Related]
7. In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method.
Lee JH; Basith S; Cui M; Kim B; Choi S
SAR QSAR Environ Res; 2017 Oct; 28(10):863-874. PubMed ID: 29183231
[TBL] [Abstract][Full Text] [Related]
8. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and substrates by using support vector machines.
Yap CW; Chen YZ
J Chem Inf Model; 2005; 45(4):982-92. PubMed ID: 16045292
[TBL] [Abstract][Full Text] [Related]
9. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9.
Goldwaser E; Laurent C; Lagarde N; Fabrega S; Nay L; Villoutreix BO; Jelsch C; Nicot AB; Loriot MA; Miteva MA
PLoS Comput Biol; 2022 Jan; 18(1):e1009820. PubMed ID: 35081108
[TBL] [Abstract][Full Text] [Related]
11. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
[TBL] [Abstract][Full Text] [Related]
12. DEEPCYPs: A deep learning platform for enhanced cytochrome P450 activity prediction.
Ai D; Cai H; Wei J; Zhao D; Chen Y; Wang L
Front Pharmacol; 2023; 14():1099093. PubMed ID: 37101544
[TBL] [Abstract][Full Text] [Related]
13. iCYP-MFE: Identifying Human Cytochrome P450 Inhibitors Using Multitask Learning and Molecular Fingerprint-Embedded Encoding.
Nguyen-Vo TH; Trinh QH; Nguyen L; Nguyen-Hoang PU; Nguyen TN; Nguyen DT; Nguyen BP; Le L
J Chem Inf Model; 2022 Nov; 62(21):5059-5068. PubMed ID: 34672553
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
16. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
Brown HS; Galetin A; Hallifax D; Houston JB
Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
[TBL] [Abstract][Full Text] [Related]
17. Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.
Beck TC; Beck KR; Morningstar J; Benjamin MM; Norris RA
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34067565
[TBL] [Abstract][Full Text] [Related]
18. In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms.
Dmitriev AV; Rudik AV; Karasev DA; Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924315
[TBL] [Abstract][Full Text] [Related]
19. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing.
Ouzounis S; Panagiotopoulos V; Bafiti V; Zoumpoulakis P; Cavouras D; Kalatzis I; Matsoukas MT; Katsila T
OMICS; 2023 Jul; 27(7):305-314. PubMed ID: 37406257
[TBL] [Abstract][Full Text] [Related]
20. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
